Welcome Guest | Login | Register | Why Register?
HOME | CONTACT | NEWS | DOCUMENT LIBRARY | FEATURES | COMMENT & ANALYSIS | EVENTS | RESEARCH REPORTS | CASE STUDIES | FORUMS

Map of Medicine partners with DH cancer networks

05 Jun 2008

The Map of Medicine is partnering with all cancer networks across England to localise the cancer care pathways already provided by ‘the Map’.

The Department of Health say the partnership is key to enabling the networks to achieve targets set out in the ‘Cancer Reform Strategy’, including improving early detection of cancers, reducing referral times and extending screening programmes.

Professor Mike Richards, national cancer director, said: “One of our key areas for action, highlighted in the ‘Cancer Reform Strategy,’ is to reduce cancer inequalities.

“This unique initiative between the Map of Medicine and the cancer networks will help us in achieving this aim.”

A recent DH survey found that women are not always being appropriately referred for breast cancer and that, in some cases, GPs are unsure when to refer breast cancer patients as urgent cases. Inappropriate referrals can have a direct impact on the quality of care received by some cancer patients across the country.

By localising the evidence based cancer pathways, which are already available on the Map of Medicine, the cancer networks will help improve the standardisation of cancer services. The integration with Map of Medicine should help ensure all healthcare professionals working in the NHS in England can access the latest evidence and guidance on cancer care and management, the company says.

There are already 120 Map of Medicine care pathways or ‘Healthguides’ accessible directly to patients via the NHS Choices website.

Links

Map of Medicine

© 2008 E-HEALTH-MEDIA LTD. ALL RIGHTS RESERVED.

1

Another clumsy advertorial ?

06 Jun 08 23:01

The news could include the current uncertainty over the status of hosting for the Map in the South, or the lack of tie in between the maps as represented on healthguides (very techno-medic-babble to the average patient), and any localisation done on the NHS versions.

These problems have been known for some time, and not resolved to my knowledge.

And I am not sure the article clarifies for me at all how tie in between MoM, DoH and the cancer networks, and magical nationwide localisation will work, given the challenges on governance and take-up of the tool.

I think it could be a very useful tool, and not just for Cancer. Just a shame that it is taking so long to get sensible progress.

Search
News Features Jobs Newsletters
Top jobs
More
Top jobs

Featured_recruiters
Featured_recruiters